Chairman & CEO
Sam J. Reich
Samuel J. Reich currently serves as Chairman and CEO of SAB Biotherapeutics. He served as executive chairman of our board of directors since our business combination with Big Cypress Acquisition Corp in October 2021 and was elected CEO of SAB in January 2024.
Co-Founder & President
Eddie J. Sullivan
Eddie J. Sullivan, PhD, is our co-founder and president since 2014. Dr. Sullivan has served in biopharma leadership positions for more than 25 years. Prior to joining us, he held the CEO role or other leadership roles in our predecessor entities, including CEO of Hematech, a subsidiary of Kyowa
Director
Katie Ellias
Katie Ellias joined SAB's Board of Directors in November 2023, bringing more than twenty years of health care and investment experience to SAB. Ms. Ellias serves as a Managing Director at the JDRF T1D Fund LLC, a venture philanthropy fund with approximately $200 million in assets, including an
Director
Christine Hamilton
Christine Hamilton, MBA, is our co-founder and has served as a member of our board of directors since 2014. Ms. Hamilton is the co-owner and managing partner of Christiansen Land and Cattle, Ltd., a large diversified farming and ranching operation in central South Dakota, and is also the co-owner
Co-Founder, Board Observer
Eddie Hamilton
Played a key role in national development of Standardized Performance Analysis (SPA) Co-Founder and member of the Board of Managers of BioDak, LLC Board member of MHCH Family Foundation Past President of the Farm Financial Standards Council Dr. Edward Hamilton is a large animal veterinarian and
Board Observer
Hong
Jae is the President and Chief Operating Officer of Sessa Capital, where he is responsible for all aspects of the firm not directly related to the investment decision making process. Prior to joining Sessa Capital in 2015, Jae was the COO and Partner at Mudrick Capital from 2012 to 2015.
Director
Dr. William J. Polvino
Dr. William J. Polvino, MD, has served as a member of our board of directors since 2019, after having served as our business advisor for several years. Dr. Polvino is pharmaceutical entrepreneur with more than 25 years of experience in the healthcare arena.
Director
Jeffrey G. Spragens
Jeffrey G. Spragens has served as a member of our board of directors since November 2020. From 2005 through 2013, Mr. Spragens was a Co-Founder and the CEO of SafeStitch Medical, Inc., a medical device company that pioneered incisionless surgery techniques that helps to relieve GERD and obesity.